BHST
BioHarvest Sciences Inc.
BHST's outlook is improving, though it still trails on the overall score.
VRT
Vertiv Holdings Co
VRT has the edge over BHST overall, supported by stronger valuation and stronger fundamentals.
BHST Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Unavailable |
BHST's revenue is currently stable, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
VRT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
VRT's revenue, profitability, cash flow and balance sheet are all currently strong.
BHST PE Valuation
BHST has no meaningful PE right now: it lost money over the past year.
VRT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 23x | $210 | — |
| Current | 39x | $210 | — |
| Cheap | 58x | $308 | +47% |
| Fair | 72x | $383 | +83% |
| Expensive | 88x | $472 | +125% |
Historical ranges are pointers, not guarantees.
VRT's PE is in its cheap range at 39x. If earnings grow as analysts expect, today's price would be 23x next year's earnings.
BHST Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect BHST's losses to shrink, with revenue growing.
VRT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
Analysts expect strong earnings and revenue growth for VRT, with profitability improving.
BHST Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.54 | +$0.16 |
| Q1 2026 | -$0.62 | -$0.12 |
| Q4 2025 | -$0.63 | +$0.22 |
| Q3 2025 | -$0.68 | +$0.54 |
| Q2 2025 | -$0.70 | +$0.49 |
| Q1 2025 | -$0.50 | +$0.86 |
| Q4 2024 | -$0.85 | +$0.09 |
| Q3 2024 | -$1.22 | -$0.61 |
BHST is still losing money, but far less than before: $0.54 per share over the past year, against $1.36 at its worst in early 2024.
VRT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.14 | +71% |
| Q3 2026 | $5.35 | +102% |
| Q2 2026 | $4.42 | +111% |
| Q1 2026 | $3.98 | +131% |
| Q4 2025 | $3.41 | +166% |
| Q3 2025 | $2.65 | +75% |
| Q2 2025 | $2.09 | +62% |
| Q1 2025 | $1.72 | +64% |
| Q4 2024 | $1.28 | +7.6% |
VRT has the edge over BHST on earnings quality, reporting a profit while its opponent remains loss making.
BHST Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $8.8M | +3.8% |
| Q1 2026 | $8.5M | +8.2% |
| Q4 2025 | $9.1M | +25% |
| Q3 2025 | $9.1M | +39% |
| Q2 2025 | $8.5M | +41% |
| Q1 2025 | $7.9M | +47% |
| Q4 2024 | $7.3M | +61% |
| Q3 2024 | $6.5M | +102% |
BHST has the edge over VRT on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -28% | -7.1 points |
| Q1 2026 | -22% | +0.3 points |
| Q4 2025 | -12% | +11 points |
| Q3 2025 | -10% | +22 points |
| Q2 2025 | -21% | +8.1 points |
| Q1 2025 | -22% | +4.8 points |
| Q4 2024 | -23% | +33 points |
| Q3 2024 | -32% | +30 points |
BHST's operating margin was −28% last quarter, down 7.1 points from the same quarter a year ago.
VRT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.3B | +61% |
| Q2 2026 | $3.3B | +24% |
| Q1 2026 | $2.6B | +30% |
| Q4 2025 | $2.9B | +23% |
| Q3 2025 | $2.7B | +29% |
| Q2 2025 | $2.6B | +35% |
| Q1 2025 | $2B | +24% |
| Q4 2024 | $2.3B | +26% |
VRT's revenue has grown year over year every quarter since late 2020: $4.3B last quarter, up 61% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +3.5 points |
| Q2 2026 | 19% | +2.7 points |
| Q1 2026 | 17% | +2.3 points |
| Q4 2025 | 20% | +0.7 points |
| Q3 2025 | 19% | +1.4 points |
| Q2 2025 | 17% | -0.4 points |
| Q1 2025 | 14% | +1.9 points |
| Q4 2024 | 19% | +4.2 points |
VRT has the edge over BHST on profitability, with a higher operating margin.
BHST Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$3.3M | -$1.2M |
| Q1 2026 | -$2.2M | -$59K |
| Q4 2025 | -$2.9M | +$387.3K |
| Q3 2025 | -$2.5M | -$270.7K |
| Q2 2025 | -$2.1M | +$542.1K |
| Q1 2025 | -$2.1M | -$311K |
| Q4 2024 | -$3.3M | -$126.9K |
| Q3 2024 | -$2.3M | -$836K |
BHST has burned cash in almost every quarter: −$11M over the past year, against −$10M the year before.
VRT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $654.9M | +41% |
| Q2 2026 | $926.5M | +233% |
| Q1 2026 | $654.2M | +145% |
| Q4 2025 | $885.6M | +143% |
| Q3 2025 | $463.5M | +36% |
| Q2 2025 | $277.9M | -19% |
| Q1 2025 | $266.8M | +162% |
| Q4 2024 | $364.5M | +18% |
VRT has the edge over BHST on cash generation, producing positive trailing cash flow while its opponent burns cash.
BHST Net Leverage
BHST's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
VRT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 1.0x | Healthy |
VRT has more cash than debt.
BHST Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.6 | Neutral |
| Stochastic | 17.3 | Oversold |
BHST's weekly RSI is 33 (neutral) and its Stochastic is 17 (oversold).
VRT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 26.4 | Neutral |
VRT's weekly RSI is 43 (neutral) and its Stochastic is 26 (neutral).
BHST PE vs Industrials Sector
BHST has no meaningful PE right now: it lost money over the past year.
VRT PE vs Industrials Sector
| Metric | VRT | Sector median | Relative |
|---|---|---|---|
| PE | 39x | 24x | 63% above |
| PE % | 3 | 58 | 55 pts below |
VRT is trading at 39x earnings, a 63% premium to the Industrials sector's median of 24x.
BHST Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.63 | 0% above |
| 20 week MA | $1.97 | 17% below |
| 50 week MA | $3.45 | 53% below |
| 100 week MA | $5.30 | 69% below |
VRT has stronger trend alignment. BHST is above 1 of 4 weekly averages versus VRT above 2 of 5.
VRT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $221.8 | 5.5% below |
| 20 week MA | $254.4 | 18% below |
| 50 week MA | $253.9 | 17% below |
| 100 week MA | $189.1 | 11% above |
| 200 week MA | $123.5 | 70% above |
VRT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 70% above its 200-week average.
BHST Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $4.80 | $6.15 | +28% |
| 2025 | $6.15 | $5.33 | -13% |
| 2026 YTD | $5.33 | $1.63 | -69% |
BHST has finished lower in one of the last two years. It's down 69% so far in 2026.
VRT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.9 | $18.9 | +73% |
| 2021 | $18.9 | $24.9 | +31% |
| 2022 | $24.9 | $12.8 | -48% |
| 2023 | $12.8 | $48.0 | +275% |
| 2024 | $48.0 | $115.1 | +140% |
| 2025 | $115.1 | $167.6 | +46% |
| 2026 YTD | $167.6 | $209.6 | +25% |
VRT has the edge over BHST on returns for 2026, with the stronger performance.